The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Adenosine promotes alternative macrophage activation via A2A and A2B receptors
Open accessAbstract
Adenosine has been implicated in suppressing the proinflammatory responses of classically activated macrophages induced by Th1 cytokines. Alternative macrophage activation is induced by the Th2 cytokines interleukin (IL)‐4 and IL‐13; however, the role of adenosine in governing alternative macrophage activation is unknown. We show here that adenosine treatment of IL‐4‐ or IL‐13‐activated macrophages augments the expression of alternative macrophage markers arginase‐1, tissue inhibitor of matrix metalloproteinase‐1 (TIMP‐1), and macrophage galactose‐type C‐type lectin‐1. The stimulatory effect of adenosine required primarily A2B receptors because the nonselective adenosine receptor agonist 5'‐ N ‐ethylcarboxamidoadenosine (NECA) increased both arginase activity (EC50=261.8 nM) and TIMP‐1 production (EC50=80.67 nM), and both pharmacologic and genetic blockade of A2B receptors prevented the effect of NECA. A2A receptors also contributed to the adenosine augmentation of IL4‐induced TIMP‐1 release, as both adenosine and NECA were less efficacious in augmenting TIMP‐1 release by A2A receptor‐deficient than control macrophages. Of the transcription factors known to drive alternative macrophage activation, CCAAT‐enhancer‐binding protein β was required, while cAMP response element‐binding protein and signal transducer and activator of transcription 6 were dispensable in mediating the effect of adenosine. We propose that adenosine receptor activation suppresses inflammation and promotes tissue restitution, in part, by promoting alternative macrophage activation. Csóka, B., Selmeczy, Z., Koscsó, B., Németh, Z. H., Pacher, P., Murray, P. J., Kepka‐Lenhart, D., Morris S. M., Jr., Gause, W. C., Leibovich, S. J., Haskó, G. Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J. 26, 376–386 (2012). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431 · cited 2×
“4 transmembrane adenosine receptors, designated A1, A2A, A2B, and A3 (22).”
BackgroundAdenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
Self-citationMolecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue Protection
Linden, J. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.775 · Cited by 685
Goerdt, S., & Orfanos, C. E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80014-x · Cited by 682
Munder, M., Eichmann, K., & Modolell, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5347 · Cited by 647
El Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J., König, T., Schleicher, U., Koo, M.-S., et al. (2008) · Nature Immunology · doi:10.1038/ni.1671 · Cited by 646 · cited 1×
“Previous studies have proposed that arginase-1 promoter activity in macrophages is regulated by STAT-6 and C/EBP (31, 36, 47, 48).”
BackgroundSelf-citationRuffell, D., Mourkioti, F., Gambardella, A., Kirstetter, P., Lopez, R. G., Rosenthal, N., & Nerlov, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908641106 · Cited by 626 · cited 13×
“In addition, we excluded a role for STAT-6 in mediating the augmenting effect of adenosine on arginase activity, as we found that IL-4-induced STAT-6 activation was not increased but actually decreased by adenosine (Fig.”
BackgroundInfluentialObstacles and opportunities for understanding macrophage polarization
Murray, P. J., & Wynn, T. A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0710409 · Cited by 563
Self-citationHaskó, G., Szabó, C., Németh, Z. H., Kvetan, V, Pastores, S. M., & Vizi, E. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4634 · Cited by 536
Self-citationRegulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
Sitkovsky, M., & Lukashev, D. (2005) · Nature Reviews Immunology · doi:10.1038/nri1685 · Cited by 518
Haskó, G., Kuhel, D. G., Chen, J.-F., Schwarzschild, M. A., Deitch, E. A., Mabley, J. G., Marton, A., & Szabó, C. (2000) · The FASEB Journal · doi:10.1096/fj.99-0508com · Cited by 512
Self-citationTumor-induced immune dysfunction: the macrophage connection
Elgert, K. D., Alleva, D. G., & Mullins, D. W. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.275 · Cited by 426
Feoktistov, I., & Biaggioni, I. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01339-5 · Cited by 421
Van Ginderachter, J. A., Movahedi, K., Hassanzadeh Ghassabeh, G., Meerschaut, S., Beschin, A., Raes, G., & De Baetselier, P. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.06.002 · Cited by 371
Corraliza, I. M., Soler, G., Eichmann, K., & Modolell, M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1094 · Cited by 365
Temporal expression of different pathways of 1-arginine metabolism in healing wounds.
Albina, J. E., Mills, C. D., Henry, W. L., & Caldwell, M. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.10.3877 · Cited by 351
The A2B adenosine receptor protects against inflammation and excessive vascular adhesion
Yang, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27933 · Cited by 349
Alternatively activated macrophages in helminth infections
Kreider, T., Anthony, R. M., Urban, J. F., & Gause, W. C. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.002 · Cited by 304
Self-citationAlternatively activated macrophages during parasite infections
Noël, W. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.01.004 · Cited by 301
Németh, Z. H., Lutz, C. S., Csóka, B., Deitch, E. A., Leibovich, S. J., Gause, W. C., Tone, M., Pacher, P., Vizi, E. S., & Haskó, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8260 · Cited by 291
Self-citationPinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G.-J., & Leibovich, S. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63698-x · Cited by 278 · cited 1×
“(23) production by LPS or bacteria-activated macro-”
Self-citationRaes, G., Brys, L., Dahal, B. K., Brandt, J., Grooten, J., Brombacher, F., Vanham, G., Noël, W., Bogaert, P., Boonefaes, T., et al. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304212 · Cited by 246
Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression
Pauleau, A.-L., Rutschman, R., Lang, R., Pernis, A., Watowich, S. S., & Murray, P. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7565 · Cited by 243
Self-citationWelch, J. S., Escoubet-Lozach, L., Sykes, D. B., Liddiard, K., Greaves, D. R., & Glass, C. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205873200 · Cited by 233
A2B adenosine receptors in immunity and inflammation
Haskó, G., Csóka, B., Németh, Z. H., Vizi, E. S., & Pacher, P. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.04.001 · Cited by 232
Self-citationShaping of monocyte and macrophage function by adenosine receptors
Haskó, G., Pacher, P., Deitch, E. A., & Vizi, E. S. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.003 · Cited by 224
Self-citationCsóka, B., Németh, Z. H., Virág, L., Gergely, P., Leibovich, S. J., Pacher, P., Sun, C.-X., Blackburn, M. R., Vizi, E. S., Deitch, E. A., et al. (2007) · Blood · doi:10.1182/blood-2007-01-065870 · Cited by 204
Self-citationKreckler, L. M., Wan, T. C., Ge, Z.-D., & Auchampach, J. A. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096016 · Cited by 196
Gray, M. J., Poljakovic, M., Kepka-Lenhart, D., & Morris, S. M. (2005) · Gene · doi:10.1016/j.gene.2005.04.004 · Cited by 191
Self-citationXaus, J., Mirabet, M., Lloberas, J., Soler, C., Lluı́s, C., Franco, R., & Celada, A. (1999) · PubMed · Cited by 184
Adenosine Receptors and Inflammation
Blackburn, M. R., Vance, C. O., Morschl, E., & Wilson, C. N. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-89615-9_8 · Cited by 171
Qualls, J. E., Neale, G., Smith, A. M., Koo, M.-S., DeFreitas, A. A., Zhang, H., Kaplan, G., Watowich, S. S., & Murray, P. J. (2010) · Science Signaling · doi:10.1126/scisignal.2000955 · Cited by 167
Self-citationThe A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells
Wilson, J. M., Ross, W. G., Agbai, O. N., Frazier, R., Figler, R. A., Rieger, J. M., Linden, J. M., & Ernst, P. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801279 · Cited by 158
Xaus, J., Mirabet, M., Lloberas, J., Soler, C., Lluis, C., Franco, R., & Celada, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3607 · Cited by 158
Feoktistov, I., Goldstein, A. E., & Biaggioni, I. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23035-2 · Cited by 133
A2B Adenosine Receptors Protect against Sepsis-Induced Mortality by Dampening Excessive Inflammation
Csóka, B., Németh, Z. H., Rosenberger, P., Eltzschig, H. K., Spolarics, Z., Pacher, P., Selmeczy, Z., Koscsó, B., Himer, L., Vizi, E. S., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901295 · Cited by 132
Self-citationHart, M. L., Jacobi, B., Schittenhelm, J., Henn, M., & Eltzschig, H. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802193 · Cited by 122
Gorgoni, B., Maritano, D., Marthyn, P., Righi, M., & Poli, V. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4055 · Cited by 115
Ryzhov, S. V., Zaynagetdinov, R., Goldstein, A. E., Novitskiy, S. V., Blackburn, M. R., Biaggioni, I., & Feoktistov, I. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131540 · Cited by 114
Macrophages orchestrate the immune response to tumor cell death.
Gough, M. J., Melcher, A. A., Ahmed, A. U., Crittenden, M. R., Riddle, D. S., Linardakis, E., Ruchatz, A., Emiliusen, L., & Vile, R. G. (2001) · PubMed · Cited by 104
Belikoff, B. G., Hatfield, S. M., Georgiev, P., Ohta, A., Lukashev, D. E., Buras, J. A., Remick, D. G., & Sitkovsky, M. V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001567 · Cited by 99
Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism
Németh, Z. H., Leibovich, S. J., Deitch, E. A., Sperlágh, B., Virág, L., Vizi, E. S., Szabó, C., & Haskó, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.006 · Cited by 78
Self-citationReduced Expression of STAT4 and IFN-γ in Macrophages from BALB/c Mice
Kuroda, E., Kito, T., & Yamashita, U. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5477 · Cited by 68
Ratthé, C., Pelletier, M., Chiasson, S., & Girard, D. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306209 · Cited by 56
Inhibition of phosphodiesterase 4 amplifies cytokine-dependent induction of arginase in macrophages
Erdely, A., Kepka‐Lenhart, D., Clark, M., Zeidler-Erdely, P. C., Poljakovic, M., Calhoun, W. J., & Morris, S. M. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00326.2005 · Cited by 51
Self-citationChen, H., Yang, D., Carroll, S. H., Eltzschig, H. K., & Ravid, K. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.02.001 · Cited by 50
MACROPHAGE ARGINASE REGULATION BY CCAAT/ENHANCER-BINDING PROTEIN ??
Albina, J. E., Mahoney, E. J., Daley, J. M., Szollosi, D. E., Morris, S. M., & Reichner, J. S. (2005) · Shock · doi:10.1097/01.shk.0000148054.74268.e2 · Cited by 45
IL-4 REGULATION OF p38 MAPK SIGNALLING IS DEPENDENT ON CELL TYPE
Hunt, A. E., Williams, L. M., Lali, F. V., & Foxwell, B. M. J. (2002) · Cytokine · doi:10.1006/cyto.2002.1043 · Cited by 42
Upregulation of MUC5AC gene expression by IL‐4 through CREB in Human airway epithelial cells
Kim, C. H., Kim, K. E., Yoon, J., et al. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22330 · Cited by 33
IL-4-dependent CD86 expression requires JAK/STAT6 activation and is negatively regulated by PKCδ
Deszo, E. L., Brake, D. K., Kelley, K. W., & Freund, G. G. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00137-2 · Cited by 27
Role of A2A adenosine receptors in regulation of opsonized E. coli-induced macrophage function
Csóka, B., Németh, Z. H., Selmeczy, Z., Koscsó, B., Pacher, P., Vizi, E. S., Deitch, E. A., & Haskó, G. (2007) · Purinergic Signalling · doi:10.1007/s11302-007-9075-x · Cited by 20
Self-citation
Cited by
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Rőszer, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/816460 · Cited by 1,762
Metabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692
“Moreover, adenosine, through the A2B and A2A adenosine receptors, strongly promotes IL-4 driven M2 activation in macrophages (Csóka et al., 2012).”
BackgroundThe cancer metabolic reprogramming and immune response
Xia, L., Oyang, L., Lin, J., Tan, S., Han, Y., Wu, N., Yi, P., Tang, L., Pan, Q., Rao, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01316-8 · Cited by 1,312
CD39 and CD73 in immunity and inflammation
Antonioli, L., Pacher, P., Vizi, E. S., & Haskó, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.005 · Cited by 1,263
Self-citationThe ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927
Metadata
- Authors
- Csóka, B., Selmeczy, Z., Koscsó, B., Németh, Z. H., Pacher, P., Murray, P. J., Kepka‐Lenhart, D., Jr., S. M. M., Gause, W. C., Leibovich, S. J., & Haskó, G.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2011-09-16
- Volume
- 26
- Issue
- 1
- Pages
- 376-386
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2035964694
- Cited by
- 376
- References
- 56
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.